Journal
TROPICAL MEDICINE & INTERNATIONAL HEALTH
Volume 15, Issue 11, Pages 1289-1299Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1365-3156.2010.02625.x
Keywords
diabetes; tuberculosis control; epidemiology
Funding
- Netherlands Foundations of Scientific Research (NWO)
- Netherlands Organization for Advancement of Tropical Research (NWO-WOTRO)
- PRIOR
Ask authors/readers for more resources
OBJECTIVES To review the current knowledge about tuberculosis (TB) and diabetes, assessing the implication of the global increase of diabetes for TB control and patient care. METHODS Systematic literature review. RESULTS Using public databases, it can be estimated that 12.6% (95% CI 9.2-17.3%) of new TB cases in the 10 countries with the highest TB burden will be attributable to TB in 2030, a relative increase of 25.5% compared to 2010. Diabetes is associated with a higher age and body weight among patients with TB, but probably not with a specific clinical presentation of TB. Rifampicin hampers glycemic control by increasing the metabolism of most oral antidiabetic drugs, while diabetes patients may have lower concentrations of anti-TB drugs. This might be one factor contributing to higher TB treatment failure rates. CONCLUSIONS The global epidemic of diabetes has implications for control and treatment of TB. Prospective studies are needed to improve prevention, early detection and treatment of concomitant diabetes and TB, especially in developing countries.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available